Brief Reports Open Access
Copyright ©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 15, 2004; 10(12): 1819-1821
Published online Jun 15, 2004. doi: 10.3748/wjg.v10.i12.1819
Comparison of nuclear matrix proteins between gastric cancer and normal gastric tissue
Qin-Xian Zhang, Yi Ding, Xiao-Ping Le, Wei Zhang, Molecular Cell Biology Research Center, Medical College of Zhengzhou University, Zhengzhou 450052, Henan Province, China
Zhuo Li, Ling Sun, Hui-Rong Shi, Henan Key Laboratory of Molecular Medicine, Zhengzhou 450052, Henan Province, China
Author contributions: All authors contributed equally to the work.
Supported by the National Natural Science Foundation of China, No. 39170440
Correspondence to: Professor. Qin-Xian Zhang, Molecular Cell Biology Research Center, Medical College of Zhengzhou University, 40 Daxue Lu, Zhengzhou 450052, Henan Province, China. qxz53@zzu.edu.cn
Telephone: +86-371-6977002
Received: August 5, 2003
Revised: October 15, 2003
Accepted: October 22, 2003
Published online: June 15, 2004

Abstract

AIM: To study the alteration of nuclear matrix proteins (NMPs) in gastric cancer.

METHODS: The NMPs extracted from 22 cases of gastric cancer and normal gastric tissues were investigated by SDS-PAGE technique and the data were analyzed using Genetools analysis software.

RESULTS: Compared with normal gastric tissue, the expression of 30 ku and 28 ku NMPs in gastric cancer decreased significantly (P = 0.002, P = 0.001, P < 0.05). No significant difference was found in the expression of the two NMPs between the various differentiated grades (P = 0.947, P = 0.356) and clinical stages of gastric cancer (P = 0.920, P = 0.243, P > 0.05).

CONCLUSION: The results suggested that the alteration of NMPs in gastric cancer occurred at the early stage of gastric cancer development.




INTRODUCTION

Nuclear matrix (NM) is the structural framework of the nucleus comprising the peripheral lamins and pore complexes, an internal ribonucleic protein outside nucleoli[1]. Nuclear matrix proteins (NMPs) are important for a variety of cell functions, including nuclear assembly, replication, transcription, and nuclear integrity[2]. Specific changes of NMPs are associated with many cancers[3-6]. However, the alteration of NMPs in gastric cancer has not been reported. In this paper, the NMPs in gastric cancer and normal gastric tissue were studied by SDS-PAGE and Genetools quantitative analysis software.

MATERIALS AND METHODS
Materials

Twenty-two cases of gastric cancer specimens (with no history of radio- or chemotherapy preoperatively) and normal gastric mucosa were collected from the First Affiliated Hospital of Medical College of Zhengzhou University and the People’s Hospital of Henan Province. All the specimens were diagnosed pathologically (well and moderately differentiated cancers in 10 cases, poorly differentiated cancers in 12 cases). According to the PTNM of International Alliance of Anticancer in 1987, the specimens were divided into 4 clinical stages, Nine were at stage I and II, and 13 at stage III and IV.

Preparation of nuclei

The gastric cancers and normal gastric tissues were minced and mixed with STM (0.25 mol/L sucrose, 10 mmol/L Tris-HCl pH7.4, 5 mmol/L MgCl2) and homogenized with a homogenizer. Nuclei were initially separated by low speed centrifugation at 750 r/min for 10 min. The pellet was suspended with STM containing 5 g/L Triton X-100 for 10 min and centrifuged at 750 r/min for 10 min. The crude nuclei were resuspended with 2 mol/L sucrose and centrifuged at 12 000 g for 10 min. The pellet containing purified nuclei was washed with STM.

Extraction of NMPs

The purified nuclei were digested with DNase I (200 U/mL) at room temperature for 45 min prior to low salt (LS) buffer (10 mmol/L Tris-HCl pH7.4, 0.2 mmol/L MgCl2) extraction and centrifuged at 1 000 r/min for 15 min. The pellet was extracted twice with high salt (HS) buffer (10 mmol/L Tris-HCl pH7.4, 2 mol/L NaCl, 0.2 mmol/L MgCl2) and centrifuged at 6 000 r/min for 15 min. Washed with LS buffer, the pellet was resuspended with 2×loading buffer and detected for the concentration of proteins in the sample.

SDS-PAGE

A 100 μg proteins were loaded in each well of 100 g/L SDS-polyacrylamide gel. The proteins were electrophoresed at constant voltage of 200 V. The gel was stained with Coomassic brilliant blue R-250 over 4 h. The protein bands were photoed with gel photography system and quantitatively analyzed with Genetools software.

Statistic analysis

Data were analyzed using nonparametric statistics with SPSS 10.0 statistic software and P < 0.05 was considered statistically significant.

RESULTS

On the gel stained with Coomassic brilliant blue R-250, many bands were exhibited in both gastric cancer and normal gastric tissue, which suggested that NMPs were abundant in these tissues. The bands of 30 ku and 28 ku NMPs in the gastric cancer were stained more lightly than those in the normal gastric tissue (Figure 1). Analyzed with Genetools quantitative software, the expression of 30 ku and 28 ku NMPs in normal gastric tissues was significantly higher than those in gastric cancer (P < 0.05). The difference of the expression of 30 ku and 28 ku NMPs between well and moderately differentiated and poorly differentiated gastric cancers was not significant (P > 0.05). There was no significant difference in the expression of the two NMPs between stageI, II and stage III, IV (P > 0.05) (Table 1).

Table 1 Comparison of the 30 ku, 28 ku bands between gastric cancer tissues and normal tissues.
Group30 ku
28 ku
nTZTZ
Normal tissue groupa227.25-3.1654.33-3.263
Gastric cancer group2212.4414.19
Well and moderately1011.60-0.06612.90-0.923
differentiated
Poorly differentiated1211.4210.33
Stage I, II911.33-0.10013.44-1.169
Stag III, IV1311.6210.15
Figure 1
Figure 1 SDS-PAGE of nuclear matrix 1 gastric carcinoma tissue; 2 adjacent cancer tissue; 3 normal tissue; 4 marker.
DISCUSSION

NM is the structural framework of the nucleus[7], and is involved in a variety of cell functions, including DNA replication[8], RNA transcription[9], architecture of chromatin[10], carcinogenesis[11] and apoptosis[12]. The study on the relationship between NMPs and carcinogenesis has been carried out for a few years. In the experiment of Spencer et al[13], specific changes in NMPs of breast cell line were identified by two-dimensional gel electrophoresis. NMP66 was evaluated as a potential biomarker for early breast cancer in large-scale clinical trials[11]. The extent of chromosomal rearrangements correlates positively with the level of expression of the nuclear matrix high mobility group (HMG) proteins HMG I (Y) when tested in three human prostate cancer cell lines (PC-3 > DU145 > LNCaP)[14]. Using both one-dimensional and high-resolution two-dimensional immunoblot analyses, Leman et al[15] found that, in the transgenic adenocarcinoma of mouse prostate (TRAMP) model, HMG I (Y) was an NMP expressed as two protein bands with a molecular mass of 22-24 ku and HMG I (Y) expression was correlated with neoplastic and malignant properties in late stage of prostate tumor TRAMP model. In 26 pairs of human prostate cancer and normal tissue, Ishiguro et al[16] identified a specific upregulated gene encoding a 55 ku nuclear matrix protein (nmt55) by RT-PCR and real time quantitative PCR. nmt55 gene expression in human prostate cancer tissue was higher (20/26) than that in normal prostate tissue.

NMP22 has been identified as a tumor marker for transitional cell carcinoma of urinary tract[17] and bladder cancer[18-21]. Eissa et al[22] evaluated the diagnostic efficacy of NMP22, fibronectin and urinary bladder cancer antigen (UBC) in comparison with voided urine cytology on the detection of bladder cancer. They found that NMP22 and fibronectin had superior sensitivities compared to UBC and voided urine cytology, while NMP22 and voided urine cytology had the highest specificities. Xu[23] reported that the examination of NMP22 in urine was a rapid and effective way to detect the recurrence of bladder cancer. The urinary NMP22 levels were significantly higher in the renal cell carcinoma group than in the control group. The urinary NMP22 might be used in the evaluation of patients at risk of renal cell carcinoma[24]. Konety et al[25] reported that the BLCA-4 was a very sensitive and specific marker for bladder cancer.

NMPs alterations were also associated with the cancer of digestive tract. Chen et al[26] found that the interaction between HPV-16 E6 and nuclear matrix might contribute to virus induced carcinogenesis in esophageal carcinoma. Brunagel et al[27] analyzed the NMPs expression by high-resolution two-dimensional gel electrophoresis, and found that the NMP composition was able to differentiate liver metastases from normal liver tissue and normal hepatocytes. In 2003, they identified an NMP, calreticulin, which was expressed much more strongly in colon cancer compared to adjacent and normal colon tissue[28]. In our study, we found that the expression of 30 ku, 28 ku NMPs was significantly reduced in gastric cancer when compared with that in the normal gastric tissue (P < 0.05). There were no significant differences in the expression of these two proteins between the various differentiation grades and clinical stages of the gastric cancer. The results suggested that the changes of NMPs in gastric cancer might occur at early stage of the tumor development.

Matrix attachment regions (MARs) are postulated to anchor chromatin onto the NM, thereby organizing genomic DNA into topologically distinct loop domains that are important in replication and transcription[29]. The p300-SAF-A interactions at MAR elements of nontranscribed genes might poise these genes for transcription[30]. NM was a key locus for CK2 signaling in the nucleus[31]. Expression of p16 gene was significantly reduced in gastric cancer. The down-regulated expression of 30 ku, 28 ku NMPs in gastric cancer might be related to the down-regulated expression of p16 gene. In our previous study, we found the hypermethylation, mutation and microsatellite instability of p16 gene in gastric cancer. The binding of NMPs to the upstream of p16 gene and its relation to the down regulated expression of p16 gene in gastric cancer will be studied further.

Footnotes

Edited by Zhu LH and Xu FM

References
1.  Leman ES, Getzenberg RH. Nuclear matrix proteins as biomarkers in prostate cancer. J Cell Biochem. 2002;86:213-223.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 29]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
2.  Holaska JM, Wilson KL, Mansharamani M. The nuclear envelope, lamins and nuclear assembly. Curr Opin Cell Biol. 2002;14:357-364.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 93]  [Cited by in F6Publishing: 99]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
3.  Pavao M, Huang YH, Hafer LJ, Moreland RB, Traish AM. Immunodetection of nmt55/p54nrb isoforms in human breast cancer. BMC Cancer. 2001;1:15.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 30]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
4.  Ishii T, Okadome A, Takeuchi F, Hiratsuka Y. Urinary levels of nuclear matrix protein 22 in patients with urinary diversion. Urology. 2001;58:940-942.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 6]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
5.  Brünagel G, Vietmeier BN, Bauer AJ, Schoen RE, Getzenberg RH. Identification of nuclear matrix protein alterations associated with human colon cancer. Cancer Res. 2002;62:2437-2442.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Leman ES, Arlotti JA, Dhir R, Greenberg N, Getzenberg RH. Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer. J Cell Biochem. 2002;86:203-212.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 9]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
7.  Philimonenko VV, Flechon JE, Hozák P. The nucleoskeleton: a permanent structure of cell nuclei regardless of their transcriptional activity. Exp Cell Res. 2001;264:201-210.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 11]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
8.  Djeliova V, Russev G, Anachkova B. Dynamics of association of origins of DNA replication with the nuclear matrix during the cell cycle. Nucleic Acids Res. 2001;29:3181-3187.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 31]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
9.  Blencowe BJ, Baurén G, Eldridge AG, Issner R, Nickerson JA, Rosonina E, Sharp PA. The SRm160/300 splicing coactivator subunits. RNA. 2000;6:111-120.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 81]  [Cited by in F6Publishing: 80]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
10.  Cremer T, Kreth G, Koester H, Fink RH, Heintzmann R, Cremer M, Solovei I, Zink D, Cremer C. Chromosome territories, interchromatin domain compartment, and nuclear matrix: an integrated view of the functional nuclear architecture. Crit Rev Eukaryot Gene Expr. 2000;10:179-212.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 158]  [Cited by in F6Publishing: 159]  [Article Influence: 6.9]  [Reference Citation Analysis (0)]
11.  Lüftner D, Possinger K. Nuclear matrix proteins as biomarkers for breast cancer. Expert Rev Mol Diagn. 2002;2:23-31.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 18]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
12.  Wang ZH, Yu D, Li HK, Chow VW, Ng CC, Chan HB, Cheng SB, Chew EC. Alteration of nuclear matrix protein composition of neuroblastoma cells after arsenic trioxide treatment. Anticancer Res. 2001;21:493-498.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Spencer VA, Samuel SK, Davie JR. Altered profiles in nuclear matrix proteins associated with DNA in situ during progression of breast cancer cells. Cancer Res. 2001;61:1362-1366.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Takaha N, Hawkins AL, Griffin CA, Isaacs WB, Coffey DS. High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells. Cancer Res. 2002;62:647-651.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Leman ES, Madigan MC, Brünagel G, Takaha N, Coffey DS, Getzenberg RH. Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer. J Cell Biochem. 2003;88:599-608.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 21]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
16.  Ishiguro H, Uemura H, Fujinami K, Ikeda N, Ohta S, Kubota Y. 55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor. Int J Cancer. 2003;105:26-32.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 35]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
17.  Shao Y, Zhuang J, Xu SX, Liu DY. [Significance of urinary nuclear matrix protein 22 in diagnosis of transitional cell carcinoma of urinary tract]. Ai Zheng. 2002;21:1005-1007.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Friedrich MG, Hellstern A, Hautmann SH, Graefen M, Conrad S, Huland E, Huland H. Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests. J Urol. 2002;168:470-474.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 34]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
19.  Parekattil SJ, Fisher HA, Kogan BA. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer. J Urol. 2003;169:917-920.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 32]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
20.  Mahnert B, Tauber S, Kriegmair M, Nagel D, Holdenrieder S, Hofmann K, Reiter W, Schmeller N, Stieber P. Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer. Clin Chem Lab Med. 2003;41:104-110.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 37]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
21.  Bhuiyan J, Akhter J, O'Kane DJ. Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder. Clin Chim Acta. 2003;331:69-77.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 19]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
22.  Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. J Urol. 2002;168:465-469.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 44]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
23.  Xu K, Tam PC, Hou S, Wang X, Bai W. The role of nuclear matrix protein 22 combined with bladder tumor antigen stat test in surveillance of recurring bladder cancer. Chin Med J (Engl). 2002;115:1736-1738.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Ozer G, Altinel M, Kocak B, Yazicioglu A, Gonenc F. Value of urinary NMP-22 in patients with renal cell carcinoma. Urology. 2002;60:593-597.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 15]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
25.  Konety BR, Nguyen TS, Dhir R, Day RS, Becich MJ, Stadler WM, Getzenberg RH. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4. Clin Cancer Res. 2000;6:2618-2625.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Chen HB, Chen L, Zhang JK, Shen ZY, Su ZJ, Cheng SB, Chew EC. Human papillomavirus 16 E6 is associated with the nuclear matrix of esophageal carcinoma cells. World J Gastroenterol. 2001;7:788-791.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Brünagel G, Schoen RE, Bauer AJ, Vietmeier BN, Getzenberg RH. Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin Cancer Res. 2002;8:3039-3045.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Brünagel G, Shah U, Schoen RE, Getzenberg RH. Identification of calreticulin as a nuclear matrix protein associated with human colon cancer. J Cell Biochem. 2003;89:238-243.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 30]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
29.  Galande S. Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer. Curr Cancer Drug Targets. 2002;2:157-190.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 37]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
30.  Martens JH, Verlaan M, Kalkhoven E, Dorsman JC, Zantema A. Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes. Mol Cell Biol. 2002;22:2598-2606.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 72]  [Cited by in F6Publishing: 77]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
31.  Wang H, Yu S, Davis AT, Ahmed K. Cell cycle dependent regulation of protein kinase CK2 signaling to the nuclear matrix. J Cell Biochem. 2003;88:812-822.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 29]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]